☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
application
Novo Nordisk Receives the US FDA's Refusal to File Letter for Semaglutide to Treat T2D
March 23, 2021
BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19
December 2, 2020
Merck KGaA Reports EMA's Validation of MAA for Tepotinib to Treat Advanced NSCLC with METex14 Skipping Alterations
November 27, 2020
Chugai Files an Application to MHLW for an Additional Indication of Kadcyla (trastuzumab emtansine) as an Adjuvant Therapy for HER...
September 2, 2019
Sun Pharma Reports Submission of Manufacturing and Marketing Authorization Application of Tildrakizumab in Japan
August 1, 2019
ViiV Healthcare Files NDA for Cabotegravir + Edurant (rilpivirine) to the US FDA to Treat HIV-1 Infection in Adults
April 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.